Diamonds and Dogs


A chink in the Armour. Under Armour (UAA) is down 26% to a 4 year low after missing earnings and sales estimates for the fourth quarter, while also announcing that its chief financial officer is leaving. On the one hand, Under Armour did deliver increases in revenue and sales, which is pretty good considering the overall apparel market, but sales look to be growing only 12% about half the annual growth rate over the last five years. Going forward, Under Armour foresees its 2017 revenue of only $5.4 billion well below estimates of $6.06 billion.

Drug stocks including Celgene (CELG) are higher in a down market after President Donald Trump met with CEOs of the biotech and pharma industries, promised to "streamline the FDA" and cut regulations so that new products can be brought to the market faster and cheaper. Trump also wants drug prices to remain low through more competitive bidding. He vowed to take on "price fixing by the biggest dog in the market, Medicare."

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.